gsdm: past present & future
DESCRIPTION
GSDM: Past Present & future. RM Clemmons, DVM, PhD, CVA, CVFT Gainesville, FL. German Shepherd Degenerative Myelopathy (GSDM). A chronic, progressive neurodegenerative disease Initial signs are due to TL spinal cord disease Represents an autoimmune disorder. Signalment. Breeds - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/1.jpg)
GSDM: PAST PRESENT & FUTURE
RM Clemmons, DVM, PhD, CVA, CVFTGainesville, FL
![Page 2: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/2.jpg)
German Shepherd Degenerative Myelopathy
(GSDM) A chronic, progressive
neurodegenerative disease
Initial signs are due to TL spinal cord disease
Represents an autoimmune disorder
![Page 3: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/3.jpg)
![Page 4: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/4.jpg)
Signalment
Breeds German Shepherd dogs Belgium Shepherds Old English Sheepdogs Rhodesian Ridgebacks Weimaraner Probably Great Pyrenes
Age > 5 years old (usually 8-
9)
Sex Equal
Onset 1 month to 1 year
Clinical Course Paralysis within 3
to 6 month without treatment
![Page 5: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/5.jpg)
Signs of GSDM
![Page 6: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/6.jpg)
Histopathology
Axon and myelin loss Swollen axons Patchy demyelination
Astrocyte proliferation
Increase in vasculature
![Page 7: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/7.jpg)
Diagnosis1. Physical and Neurologic Examination
History of chronic progressive posterior paresis in susceptible breed
TL (non-localized) dysfunction
2. Negative Neural Imaging3. Normal Electrodiagnostic Exam
Might have altered spinal evoked response
4. Abnormal CSFLumbar CSF changes
![Page 8: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/8.jpg)
Greta
Signalment
8 yr F/S GSD Weakness Posterior Paresis
S
![Page 9: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/9.jpg)
Greta History
Seemed to be slower over last 6 months Trouble getting up
Vet checked for HD Minimal response to
NSAIDs
Worse over last 30 daysS
![Page 10: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/10.jpg)
Greta
![Page 11: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/11.jpg)
Greta Neurologic Examination
Head- -NAF CN- -NAF Mild Neck Pain (C6) Forelegs- -NAF (slight
dysmetria) Rear Legs-
Slight hyperflexia L>R CP deficits Bilaterally Babinski L Hypermetria
Mild Back Pain (TL)
O
![Page 12: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/12.jpg)
Greta Localization of
Lesion D A M N N I I I T T VO
T3-L3 Spinal Cord
IVDD, GSDM
MyelitisGME
Spinal Tumor
![Page 13: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/13.jpg)
Greta Differential Dx
?
Diagnostic Approach ?
Treatment ?
P
• Problem List1. Posterior Paresis
2. Foreleg Hypermetria
3. Neck & Back Pain
1. GSDM2. IVDD3. Infect/Inflamm4. Neoplasia
![Page 14: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/14.jpg)
Greta- -Diagnostic Approach
MDB CBC Chemistry Profile UA Chest & Abdominal
Radiographs Abdominal Ultrasound
Neurologic Tests EMG CSF Analysis
Cisternal Lumbar
MRI (Whole Spine)
Client EducationP
![Page 15: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/15.jpg)
Greta- -Blood work & UA Unremarkable
O
![Page 16: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/16.jpg)
Greta- -Chest Rads
O
![Page 17: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/17.jpg)
Greta- -Abdominal Rads
O
![Page 18: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/18.jpg)
Greta- -Abdominal Ultrasound
O
![Page 19: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/19.jpg)
Greta
Differential Dx ?
Diagnostic Approach ?
Treatment ?
P
![Page 20: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/20.jpg)
Humeral Immunity
Circulating Immune-complexes 59.3 + 2.5 µg/ml
(normal = 18.7 + 2.5 µg/ml)
Contain non- specific inflammatory proteins on electrophoresis
![Page 21: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/21.jpg)
Cell-Mediated Immunity
Attenuated Response to Mytogens ConA Polkweed Mitogen PHA
Circulating Suppressor Cells
![Page 22: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/22.jpg)
Greta- -EMG Needle EMG normal NCV 55 m/sec F wave present RNS- -nondecremental SEP- -abnormal
O
Greta
![Page 23: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/23.jpg)
Spinal Cord Evoked Potential
NormalEarly DMLate DM
![Page 24: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/24.jpg)
Greta- -CSF Analysis Cisternal CSF
Color/Transparency clear
Protein mg/dL 15
RBC/μL 1
WBC/μL 1
A cell differential count yielded the following: 1% Neutrophils 89% Lymphocytes 10% Mononuclear phagocytes
Interpretation: Benign CSF
Lumbar CSF
Color/Transparency clear
Protein mg/dL 65
RBC/μL 15
WBC/μL 2
A cell differential count yielded the following: 1% Neutrophils 85% Lymphocytes 14% Mononuclear phagocytes
Interpretation: Albuminocytologic
dissociationO
![Page 25: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/25.jpg)
CSF Cholinesterase
normal DM inflam
*
*
O
• Greta• AO- - 250 IU/ml• Lumbar- - 560 IU/ml
![Page 26: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/26.jpg)
Lumbar IgG Concentration
IgG
con
cent
ratio
n
DM normal
![Page 27: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/27.jpg)
Oligoclonal Bands of IgG
![Page 28: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/28.jpg)
Oligoclonal Bands of IgG
![Page 29: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/29.jpg)
2-D Electrophoresis of CSF
Normal DM
![Page 30: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/30.jpg)
CSF Inflammatory Markers
ICAM IL6 NSE Ubiq. S100 Neop.DM Mean 1.5 1.2 1.1 0.9 0.4 1.1
SD 0.7 0.6 0.7 0.9 0.5 1.0Freq. 0.9 0.9 0.8 0.6 0.4 0.7
NIFD Mean 0.8 0.3 0.7 0.3 0.2 0.8SD 0.8 0.8 0.5 0.8 0.4 1.0
Freq. 0.7 0.2 0.7 0.2 0.2 0.5
![Page 31: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/31.jpg)
MBP assay in CSF
GSDM: 4.28 ng/ml ± 2.36
Non-Infam. ND: 0.63 ng/ml ± 0.86
(t>0.05) M
BP0
2.5
5
7.5
10
DM cont
trt
Oneway Analysis of MBP By trt
![Page 32: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/32.jpg)
MBP/TP ratio in CSF
GSDM: 0.092 ± 0.048
Non-Inlfam. ND: 0.024 ± 0.020
(t>0.05)m
bp/tp
0
0.025
0.05
0.075
0.1
0.125
0.15
DM cont
trt
Excluded Rows 1
Oneway Analysis of mbp/tp By trt
![Page 33: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/33.jpg)
Greta- -MRI Lumbar
O
![Page 34: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/34.jpg)
Greta- -MRI Thoracic
O
![Page 35: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/35.jpg)
Greta- -MRI Cervical
O
![Page 36: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/36.jpg)
Greta- -Assessment MDB was essentially normal
Mild HD/hepato- -splenomegaly
EMG demonstrated alterations consistent with spinal white matter conduction delay
CSF showed TL Albuminocytologic dissociation consistent with chronic degenerative prosess
MRI did not reveal significant structural disease
A
![Page 37: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/37.jpg)
Greta- -DM Flash Test
Results came back POSITIVE 96% sensitivity 99% specificity
1 2 3 4 5 6 7 8
Figure 3. DM Flash test. 1-4 are GSDM patients while 5-8 are GSD patients with other neurological diseases.
O
![Page 38: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/38.jpg)
GRETA- -FINAL DIAGNOSISGerman Shepherd Dog
Myelopathy
A
![Page 39: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/39.jpg)
Current Hypothesis
An Auto-Immune CNS Disease Immune-complexes damage endothelium Leads to perivascular fibrin deposition Fibrin degradation leads to leukocyte infiltration Leukocytes produce prostaglandins and
leukotreines Leads to Free-Radical production and damage
Treatment must take these steps into account
![Page 40: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/40.jpg)
Comparison of GSDM & PPMS
GSDM Progressive spinal cord
disease with myelin & axonal loss
No sex predilection
Occurs in 4-6th decade of life
Course is 7-10 years
CSF oligoclonal IgG
Non-plaque forming
Increased CSF MBP
PPMS Progressive spinal cord
disease with myelin & axonal loss
No sex predilection
Occurs in 4-6th decade of life
Course is 7-10 years
CSF oligoclonal IgG
Non-plaque forming
![Page 41: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/41.jpg)
Greta- -Client Education May expect gradual return to function
expecting 80% of recovery in 3 months
May continue to progress over 12-18 months
Need to monitor spleen and blood work every 6 months
Reassess as needed, changing medications when appropriateP
![Page 42: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/42.jpg)
Greta- -TCVM exam Tongue
Pale Wet
Pulse Weak bilaterally
Sensitivity GB 21 BL 18 BL 23
TCVM Diagnosis
Combined Qi/Yin Deficiency with Stagnation
![Page 43: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/43.jpg)
Treatment
Exercise
20-30 minutes twice a week
1 hour once a week
sustained aerobic exercise is needed
CNS O2 delivery
![Page 44: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/44.jpg)
Treatment
Dietary Considerations
Tofu Fresh vegetables
carrots greens peppers broccoli
Ginger, garlic & mustard
![Page 45: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/45.jpg)
Treatment
Supplements
Antioxidants Membrane stabilizers Tonics Anti-inflammatory
![Page 46: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/46.jpg)
Treatment
Medication
Aminocaproic acid (500 mg TID)
n-Acetylcysteine (25 mg/kg TID QD for 2 weeks, then TID QOD)
![Page 47: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/47.jpg)
Conclusion Degenerative Myelopathy appears to be
an Autoimmune Disease and Treatment must be directed at this Process.
Exercise Diet Supplements Medication
Things that CNS O2 Availability
![Page 48: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/48.jpg)
TCVM for GSDM Treat what you see
Most cases present with Wei syndrome secondary to combined Qi & Yin Deficiency
Special AP BL-62
Herbals Di Huang Yin Zi Tang (Rehmannia Decoction) Hu Qian Tang (Hidden Tiger Powder)
![Page 49: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/49.jpg)
Di Huang Yin Zi Tang(Rehmannia Decoction)
Shu Di Huang 10 gm Shan Zhu Yu 10 gmRou Cong Rong 10 gmBa Ji Tian 10 gm Fu Zi 10 gm Rou Gui - An Nan 10 gmShi Hu – fine 10 gmMai Men Dong 10 gmShi Chang Pu 10 gm Yuan Zhi 10 gmFu Ling – curled 10 gm Wu Wei Zi 10 gm
Powder herbs and mix thoroughly. Dosage is 0.5 gm/10lbs for 2 weeks and then 1 gm/10lbs.
![Page 50: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/50.jpg)
Di Huang Yin Zi Tang(Rehmannia Decoction)
Rx Principle:Nourish and tonifies kidney yin; strengthens kidney
water to pacify heart fire; warm and tonifies kidney yang; and strengthen bones and sinews of lower back.
Indications:Stiffness of tongue and hoarse voice; andparalysis of
lower extremities. Dry mouth without thirst and deep weak pulses.
Contraindications:Excess conditions with rising yang.
![Page 51: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/51.jpg)
Hu Qian Tang (Hidden Tiger Powder)
Jiu Chao Huang Bai 150 gmJiu Chao Zhi Mu 30 gmShu Di Huang 60 gmSu Zhi Gui Ban 120 gmBai Shao 60 gmHu Gu 60 gm (Substitute Chuan Niu
Xi)Suo Yang 45 gmGan Jiang 15 gmChen Pi 60 gm
Powder herbs and mix thoroughly. Dosage is 0.5 gm/10lbs for 2 weeks and then 1 gm/10lbs.
![Page 52: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/52.jpg)
Hu Qian Tang (Hidden Tiger Powder)
Rx Principle:Nourishes yin; causes fire to descend; and strengthens bones
and sinews. Treats a atrophy disorders by drying the damp and strengthening the kidney.
Indications:Weakness in lower back and knees; deterioration of the
sinews and bones with general reduction of function; wasting of muscle of the rear legs and feet; and difficult walking. Associated with red tongue and deep, weak pulses.
Contraindications:Not for atrophy due to spleen and stomach deficiency or
invasion of damp-heat.
![Page 53: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/53.jpg)
Greta- -TCVM Therapy AP
Cervical points BL10 GB 21
Lumbar points GV 14 Bai Hui (EA & Moxa) BL40 BL62
Other points ST 36 SP 6 LI 10 LIV 3
Herbal
Hu Qian Tang Walking Tiger
Formula Jing Tang
Di Huang Yin Zi Rehmannia Formula
for Paralysis Jing Tang
![Page 54: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/54.jpg)
GSDM Future Stem Cell Therapy
Currently temporary effects
Epimedium Powder Spinal EA
Polypeptides Neuroregenerative
Peptide Gelsolin
Improved Diagnostics Alternatives to
SOD1 Perhaps altered
ubiquitin pathway
![Page 55: GSDM: Past Present & future](https://reader031.vdocuments.net/reader031/viewer/2022012919/568166f9550346895ddb5a7c/html5/thumbnails/55.jpg)